This test screens for 50 cancers - but whether Medicare and other health insurers will cover it hinges on FDA approval
Guardant Health Inc GH
News
Guardant Health’s Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening
Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer
Business Insider Names Guardant Health One of America's Most Innovative Businesses
FDA Approves AstraZeneca Treatment for Advanced Breast Cancer — Update
Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced Breast Cancer
Guardant Health’s Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening
Guardant Health to Appeal Federal District Court Judgment
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Guardant Health Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
Guardant Health to Participate in Upcoming Investor Conferences
Actor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who Have Lost Their Lives to Colorectal Cancer
Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026
A new blood test can help detect colon cancer, but it's not as good as the test you hate to take
These 15 stocks are still showing momentum - and a market-beating edge
United States